Table 1.

Baseline demographic, clinical and biochemical characteristics of 22 patients with UC.

Characteristic	RIC	Sham
	n = 11	n = 11
Age [years]	41 [36–64]	41 [24–50]
Sex [female]	2 [18%]	9 [82%]
Weight [kg]	78.2 [70.8–91.2]	70.0 [63.9–88.7]
BMI [kg/cm2]	25.4 [23.9–28.6]	26.3 [22.6–28.4]
Disease duration [years]	13.2 [8.3–14.9]	5.1 [2.2–12.3]
Smoking status
Current	1 [9]	0[0]
Former	7 [64]	7 [64]
Never	3 [27]	4 [36]
Alcohol consumption
≥7/14 alcohol units per week	1 [9]	2 [18]
<7/14 alcohol units per week	10 [91]	5 [45]
No alcohol	0[0]	4 [36]
Disease extent at endoscopy
Proctitis	4 [36]	6 [55]
Left-sided UC	5 [45]	4 [36]
Pancolitis	2 [18]	1 [9]
Montréal classification
E1 - Ulcerative proctitis	3 [27]	4 [36]
E2 - Left sided UC [distal UC]	7 [64]	6 [55]
E3 - Extensive UC [pancolitis]	1 [9]	1 [9]
Medication
No treatment	4 [36]	2 [18]
Rectal 5-ASA	2 [18]	4 [36]
Oral 5-ASA	6 [55]	8 [73]
Immunosuppressants	1 [9]	1 [9]
Anti-TNF	0	0
FC	1220 [523–1808]	1391 [879–4139]
P-CRP	1.95 [1.8–8.3]	1.9 [1.6–6.1]
Mayo Score	7 [6–8]	8 [7–9]
Endoscopic Mayo Score	2 [2–2.5]	2 [2–2.5]
Days of flare prior to inclusion	78 [22.5–150]	41 [22–93]
Days of RIC/Sham	10 [9,10]	10.5 [10,11]

Continuous variables are described as median and IQR, categorical variables are described as frequencies and percentages.

UC, ulcerative colitis; BMI, body mass index; 5-ASA, 5-aminosalicylic acid; Anti-TNF, antitumor necrosis factor inhibitor; FC, Fecal calprotectin; p-CRP, plasma C-reactive protein; RIC, remote ischemic conditioning.